This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 3 EPO patents. Top assignees: Blanchette Rockefeller Neurosciences Institute, Cognitive Research Enterprises, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2003-2018.
Location History:
- Bethesda, MD (US) (2003)
- Gaithersburg, MD (US) (2004 - 2018)
Company Filing History:
2 out of 21 
1 out of 8 
1 out of 3,690 
Years Active: 2003-2018
Title: Biography of Miao-Kun Sun
Introduction: Miao-Kun Sun is a distinguished inventor based in Gaithersburg, MD (US). He has made significant contributions to the field of neuroscience, particularly in the treatment of depressive and cognitive disorders. With a total of five patents to his name, his work has the potential to impact many lives.
Latest Patents: One of his latest patents focuses on the treatment of depressive disorders. This invention provides for the use of carbonic anhydrase activators, protein kinase C activators, and FGF-18 to treat such disorders. Additionally, it relates to improved animal models and methods for screening and identifying compounds to treat depressive disorders. Another notable patent addresses cognitive disorders associated with abnormal dendritic spines. This disclosure presents methods for treating cognitive disorders, such as Fragile X Syndrome and autism, using PKC activators.
Career Highlights: Miao-Kun Sun has worked with reputable organizations, including the Blanchette Rockefeller Neurosciences Institute and the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. His work in these institutions has allowed him to advance his research and contribute to significant scientific discoveries.
Collaborations: Throughout his career, Miao-Kun Sun has collaborated with esteemed colleagues, including Daniel L. Alkon and Wei-Qin Zhao. These collaborations have enriched his research